Rep. Gilbert Ray Cisneros, Jr. sold GE HealthCare Technologies (GEHCV)
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31) · $1K–$15K · traded May 15, 2026
- Transaction
- Sold
- Amount
- $1K–$15K
- Owner
- Not stated
- Traded
- May 15, 2026
- Disclosed
- Jun 8, 2026
- Days to disclose
- 24
- Asset type
- Stock
- As filed
- GE HealthCare Technologies Inc.
- Industry
- Medical - Healthcare Information Services · Healthcare
Other trades in this filing
All of Cisneros's trades →- Jun 8, 2026$1K–$15K
$1K–$15K · Traded Jun 2, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$1K–$15K
$1K–$15K · Traded May 29, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$1K–$15K
Bought Ligand Pharmaceuticals LGND
$1K–$15K · Traded May 29, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$1K–$15K
$1K–$15K · Traded May 29, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$1K–$15K
Bought The Cooper Companies COO
$1K–$15K · Traded May 29, 2026 · disclosed Jun 8, 2026
Traded 6 days before earnings - Jun 8, 2026$1K–$15K
$1K–$15K · Traded May 29, 2026 · disclosed Jun 8, 2026
Got $1K from the company’s PAC - Jun 8, 2026$15K–$50K
$15K–$50K · Traded May 29, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$1K–$15K
Bought Texas Capital Bancshares TCBI
$1K–$15K · Traded May 29, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$1K–$15K
Sold (partial) W. R. Berkley WRB
$1K–$15K · Traded May 29, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$1K–$15K
$1K–$15K · Traded May 29, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$1K–$15K
Bought Perella Weinberg Partners PWP
$1K–$15K · Traded May 29, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$1K–$15K
Bought Arcutis Biotherapeutics ARQT
$1K–$15K · Traded May 29, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$1K–$15K
$1K–$15K · Traded May 29, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$250K–$500K
Bought New York City, NY Transitional Finance Authority Bonds
$250K–$500K · Traded May 29, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$1K–$15K
$1K–$15K · Traded May 29, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$1K–$15K
$1K–$15K · Traded May 29, 2026 · disclosed Jun 8, 2026
Traded 6 days before earnings - Jun 8, 2026$1K–$15K
$1K–$15K · Traded May 29, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$1K–$15K
$1K–$15K · Traded May 29, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$1K–$15K
Sold (partial) MACOM Technology Solutions Holdings MTSI
$1K–$15K · Traded May 22, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$1K–$15K
Sold (partial) W. R. Berkley WRB
$1K–$15K · Traded May 19, 2026 · disclosed Jun 8, 2026
Company context for GEHCV
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
GEHCV: third_quarter 2026 lobbying report
Issues impacting artificial intelligence. Issues impacting corporate taxation. Issues impacting funding for health care including government research. Issues impacting health care and public health. Issues impacting manufacturing. Issues impacting medical device and health care cybersecurity. Issues impacting medical device regulation. Issues impacting medical insurance coverage. Issues impacting medical research. Issues impacting Medicare coverage and reimbursement for medical technology and health care services. Issues impacting radiopharmacetucials. Issues impacting servicing and repair of
Public: Oct 20, 2026, 10:30 AM EDTOriginal source ↗GEHCV: second_quarter 2026 lobbying report
Issues impacting artificial intelligence. Issues impacting corporate taxation. Issues impacting funding for health care including government research. Issues impacting health care and public health. Issues impacting manufacturing. Issues impacting medical device and health care cybersecurity. Issues impacting medical device regulation. Issues impacting medical insurance coverage. Issues impacting medical research. Issues impacting Medicare coverage and reimbursement for medical technology and health care services. Issues impacting radiopharmacetucials. Issues impacting servicing and repair of
Public: Jul 20, 2026, 10:18 AM EDTOriginal source ↗
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.